Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis

Yi He; Ruijie Liu; Mei Yang; Wu Bi; Liuyin Zhou; Sai Zhang; Jin Jin; Xujun Liang; Pengfei Zhang

doi:10.3389/fonc.2021.639600

Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis

Front Oncol. 2021 Apr 22:11:639600. doi: 10.3389/fonc.2021.639600. eCollection 2021.

Authors

Yi He^{1

2}, Ruijie Liu^{1

2}, Mei Yang^{1

2}, Wu Bi^{1

2}, Liuyin Zhou², Sai Zhang^{1

2}, Jin Jin^{1

2}, Xujun Liang^{1

2}, Pengfei Zhang^{1

2}

Affiliations

¹ NHC Key Laboratory of Cancer Proteomics, Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
² National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.

Abstract

Lung adenocarcinoma (LUAD) is one of the most malignant tumors with high morbidity and mortality worldwide due to the lack of reliable methods for early diagnosis and effective treatment. It's imperative to study the mechanism of its development and explore new biomarkers for early detection of LUAD. In this study, the Gene Expression Omnibus (GEO) dataset GSE43458 and The Cancer Genome Atlas (TCGA) were used to explore the differential co-expressed genes between LUAD and normal samples. Three hundred sixity-six co-expressed genes were identified by differential gene expression analysis and Weighted Gene Co-expression Network Analysis (WGCNA) method. Those genes were mainly enriched in ameboidal-type cell migration (biological process), collagen-containing extracellular matrix (cell component), and extracellular matrix structure constituent (molecular function). The protein-protein network (PPI) was constructed and 10 hub genes were identified, including IL6, VWF, CDH5, PECAM1, EDN1, BDNF, CAV1, SPP1, TEK, and SELE. The expression level of hub genes was validated in the GEPIA database, compared with normal tissues, VWF is lowly expressed and SPP1 is upregulated in LUAD tissues. The survival analysis showed increased expression of SPP1 indicated unfavorable prognosis whereas high expression of VWF suggested favorable prognosis in LUAD (p < 0.05). Based on the immune infiltration analysis, the relationship between SPP1 and VWF expression and macrophage, neutrophil, and dendritic cell infiltration was weak in LUAD. Quantitative real-time PCR (qRT-PCR) and western blotting were used to validate the expression of VWF and SPP1 in normal human bronchial epithelial (HBE) cell and three LUAD cell lines, H1299, H1975, and A549. Immunohistochemistry (IHC) was further performed to detect the expression of VWF in 10 cases LUAD samples and matched normal tissues. In summary, the data suggest that VWF is a potential novel biomarker for prognosis of LUAD.

Keywords: VWF; bioinformatics; co-expression analysis; differential expression genes analysis; lung adenocarcinoma.